Based on blood multi-omics data, we not only revealed the causal effects of OS on BC characterized by genetic susceptibility but also identified the key regulatory gene PARK7, which exhibited robust causal associations with BC risk across multiple molecular dimensions, including methylation, gene expression, alternative splicing, and protein abundance. Here, PARK7 is linked to breast cancer.